Figures & data
Fig. 1 Graphic representation of IL-12 concentration in the serum of holoxenic mice, collected after: I – 7 days from the first oral administration of NVCs; II – 14 days from the first oral administration of NVCs; III – 21 days from the first oral administration of NVCs. IC, integral culture; CS, cellular suspension; SN, supernatant; A, serum collected from holoxenic mice after oral administration of NVC; B, serum collected from holoxenic mice after oral administration of NVC stimulated with E. coli O28C; C, serum collected from holoxenic mice after oral administration of NVC stimulated with B. cereus; MC, media control – serum collected from holoxenic mice after oral administration of MRS; NC, negative control – serum collected from holoxenic mice control.
Fig. 2 Graphic representation of TNF α concentration in the serum of holoxenic mice, collected after: I – 7 days from the first oral administration of NVCs; II – 14 days from the first oral administration of NVCs; III – 21 days from the first oral administration of NVCs. IC, integral culture, CS, cellular suspension; SN, supernatant; A, serum collected from holoxenic mice after oral administration of NVC; B, serum collected from holoxenic mice after oral administration of NVC stimulated with E. coli O28C; C, serum collected from holoxenic mice after oral administration of NVC stimulated with B. cereus; MC, media control – serum collected from holoxenic mice after oral administration of MRS; NC, negative control – serum collected from holoxenic mice control.
